tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
GlaxoSmithKline (GSK)
:GSK
US Market
GSK
GlaxoSmithKline
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

GlaxoSmithKline (GSK) Stock News & Sentiment

Compare
5,051 Followers
GSK’s Promising Phase 3 Study on Multiple Myeloma Treatment: A Market Game Changer?
Premium
Company Announcements
GSK’s Promising Phase 3 Study on Multiple Myeloma Treatment: A Market Game Changer?
2d ago
GSK
GSK’s Promising Phase 3 Study on Relapsed SCLC: A Potential Game Changer
Premium
Company Announcements
GSK’s Promising Phase 3 Study on Relapsed SCLC: A Potential Game Changer
2d ago
GSK
GSK and iTeos Advance Immunotherapy Study for Lung Cancer
Premium
Company Announcements
GSK and iTeos Advance Immunotherapy Study for Lung Cancer
14d ago
GSK
ITOS
GSK and Ideaya’s Promising Study on Solid Tumors: A Potential Game-Changer?
Premium
Company Announcements
GSK and Ideaya’s Promising Study on Solid Tumors: A Potential Game-Changer?
21d ago
GSK
IDYA
GSK’s New Study on Multiple Myeloma Treatment: What Investors Need to Know
Premium
Company Announcements
GSK’s New Study on Multiple Myeloma Treatment: What Investors Need to Know
21d ago
GSK
GSK’s Promising Study on Belimumab for Lung Disease: What Investors Need to Know
Premium
Company Announcements
GSK’s Promising Study on Belimumab for Lung Disease: What Investors Need to Know
21d ago
GSK
GSK and iTeos Therapeutics’ Promising Phase 3 Lung Cancer Study: Market Implications
Premium
Company Announcements
GSK and iTeos Therapeutics’ Promising Phase 3 Lung Cancer Study: Market Implications
21d ago
GSK
ITOS
More GSK News >

GSK News on the Web

Shore Capital Remains a Buy on GlaxoSmithKline (GSK)
TipRanks News
Neutral
GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EU
Zacks
Neutral
GSK Vault CRM rollout a 'key milestone' for Veeva, says Raymond James
The Fly
Neutral
BMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now?
Zacks
Neutral
JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug
Zacks
Neutral
GILD Stock Up 7% Post Q2 Earnings: Should You Buy Now or Wait?
Zacks
Neutral
Theravance's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y
Zacks
Neutral
GSK opens higher after priority review for new gonorrhoea pill
Proactive Investors
Neutral

News Score - Last 7 Days

Neutral
GSK
Sector Average
Media Buzz
This Week4 articles
Weekly Average4 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GSK’s Media Buzz Sentiment?
4 articles about GSK were published this week. In an average week, 4 articles are published.
    What is GSK’s weekly average amount of articles?
    In an average week, 4 articles about GSK are published.
      What is GSK’s News Sentiment?
      50% of articles about GSK were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        COOCooper Co
        PAHCPhibro Animal Health
        ANSLFAnsell
        AAgilent
        WBAWalgreens Boots Alliance
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing